140 related articles for article (PubMed ID: 12208941)
1. Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators.
Chatterji U; de Parseval A; Elder JH
J Virol; 2002 Oct; 76(19):9624-34. PubMed ID: 12208941
[TBL] [Abstract][Full Text] [Related]
2. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
[TBL] [Abstract][Full Text] [Related]
3. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity.
de Parseval A; Elder JH
J Virol; 1999 Jan; 73(1):608-17. PubMed ID: 9847366
[TBL] [Abstract][Full Text] [Related]
4. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.
Thompson FJ; Elder J; Neil JC
J Gen Virol; 1994 Mar; 75 ( Pt 3)():545-54. PubMed ID: 8126451
[TBL] [Abstract][Full Text] [Related]
5. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
[TBL] [Abstract][Full Text] [Related]
6. Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
Waters AK; De Parseval AP; Lerner DL; Neil JC; Thompson FJ; Elder JH
Virology; 1996 Jan; 215(1):10-6. PubMed ID: 8553580
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.
Phillips TR; Lamont C; Konings DA; Shacklett BL; Hamson CA; Luciw PA; Elder JH
J Virol; 1992 Sep; 66(9):5464-71. PubMed ID: 1323707
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Rev transactivation of feline immunodeficiency virus in feline and non-feline cell lines.
Tomonaga K; Miyazawa T; Kawaguchi Y; Kohmoto M; Inoshima Y; Mikami T
J Vet Med Sci; 1994 Feb; 56(1):199-201. PubMed ID: 8204756
[TBL] [Abstract][Full Text] [Related]
9. Construction and testing of orfA +/- FIV reporter viruses.
Fadel HJ; Saenz DT; Poeschla EM
Viruses; 2012 Jan; 4(1):184-99. PubMed ID: 22355458
[TBL] [Abstract][Full Text] [Related]
10. The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes.
Miyazawa T; Kohmoto M; Kawaguchi Y; Tomonaga K; Toyosaki T; Ikuta K; Adachi A; Mikami T
J Gen Virol; 1993 Aug; 74 ( Pt 8)():1573-80. PubMed ID: 8393913
[TBL] [Abstract][Full Text] [Related]
11. The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes.
Neuveut C; Vigne R; Clements JE; Sire J
Virology; 1993 Nov; 197(1):236-44. PubMed ID: 8212559
[TBL] [Abstract][Full Text] [Related]
12. OrfA downregulates feline immunodeficiency virus primary receptor CD134 on the host cell surface and is important in viral infection.
Hong Y; Fink E; Hu QY; Kiosses WB; Elder JH
J Virol; 2010 Jul; 84(14):7225-32. PubMed ID: 20463078
[TBL] [Abstract][Full Text] [Related]
13. Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1.
Kawaguchi Y; Norimine J; Miyazawa T; Kai C; Mikami T
Virology; 1992 Sep; 190(1):465-8. PubMed ID: 1326814
[TBL] [Abstract][Full Text] [Related]
14. Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.
Bigornia L; Lockridge KM; Sparger EE
J Virol; 2001 Jan; 75(2):1054-60. PubMed ID: 11134320
[TBL] [Abstract][Full Text] [Related]
15. The feline herpesvirus type 1 ICP4 down-regulates feline immunodeficiency virus long terminal repeat (LTR)-directed gene expression via the C/EBP site in the LTR.
Kawaguchi Y; Maeda K; Pecoraro MR; Inoshima Y; Jang HK; Kohmoto M; Iwatsuki K; Ikeda Y; Shimojima M; Tohya Y
J Vet Med Sci; 1995 Dec; 57(6):1129-31. PubMed ID: 8720064
[TBL] [Abstract][Full Text] [Related]
16. Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins.
Sundstrom M; Chatterji U; Schaffer L; de Rozières S; Elder JH
Virology; 2008 Feb; 371(2):394-404. PubMed ID: 17963812
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
[TBL] [Abstract][Full Text] [Related]
18. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
19. Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus.
Huisman W; Schrauwen EJ; Rimmelzwaan GF; Osterhaus AD
Virus Res; 2008 Oct; 137(1):24-32. PubMed ID: 18602181
[TBL] [Abstract][Full Text] [Related]
20. Visna virus encodes a post-transcriptional regulator of viral structural gene expression.
Tiley LS; Brown PH; Le SY; Maizel JV; Clements JE; Cullen BR
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7497-501. PubMed ID: 2170981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
